|
|
Article: DURAMED REPORTS FIRST QUARTER RESULTS FOR 1995
- Article from:
- PR Newswire
- Article date:
- May 10, 1995
CopyrightCOPYRIGHT 1995 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CINCINNATI, May 10 /PRNewswire/ -- Mr. E. Thomas Arington, Chairman and President of Duramed Pharmaceuticals, Inc. (Nasdaq: DRMD) announced today the Company's operating results for the first quarter ended March 31, 1995. The net sales were $12,581,621 resulting in net income of $1,008,347. Regarding the first quarter results, Mr. Arington stated that, "Duramed continued its commitment to increased investment in product development. Additionally, the quarter's expenses reflected increased spending for activities relating to our pending Abbreviated New Drug Application ("ANDA") for conjugated estrogens. These expenses included pro-launch start-up costs, as well as other ...